n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with su 11248 in 1 studies
Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (su 11248) | Trials (su 11248) | Recent Studies (post-2010) (su 11248) |
---|---|---|---|---|---|
214 | 5 | 58 | 4,338 | 560 | 3,200 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, S; Hussain, A; Maddock, H; Mee, C; Sandhu, H | 1 |
1 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and su 11248
Article | Year |
---|---|
Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Cell Survival; Heart; Heart Rate; Hemodynamics; HL-60 Cells; Humans; Indoles; MicroRNAs; Protein Kinase C-alpha; Pyrroles; Receptor, Adenosine A3; Signal Transduction; Sunitinib; Ventricular Function, Left | 2017 |